Trademark: 87668718
Word
APTORUM THERAPEUTICS
Status Date
Tuesday, March 30, 2021
Registration Number
6303551
Registration Date
Tuesday, March 30, 2021
Filing Date
Wednesday, November 1, 2017
Published for Opposition
Tuesday, January 12, 2021
5 Pharmaceutical preparations and traditional Chinese medicine for the diagnosis, prevention and treatment of gastro-intestinal diseases and disorders; pharmaceutical preparations for the diagnosis, prevention and treatment of diseases and disorders relating to women's health, namely, gynecological diseases and disorders, endometrial disease and disorders; pharmaceutical products and preparations and traditional Chinese medicine for the treatment of orthopedic injuries and conditions; pharmaceutical preparations and traditional Chinese medicine for the diagnosis, prevention and treatment of ophthalmological diseases, conditions and disorders; pharmaceutical preparations and traditional Chinese medicine for the diagnosis, prevention and treatment of neurological diseases and disorders; pharmaceutical preparations and traditional Chinese medicine for the diagnosis, prevention and treatment of neurodegenerative diseases and disorders; pharmaceutical preparations and traditional Chinese medicine for the diagnosis, prevention and treatment of peripheral nervous system diseases and disorders; pharmaceutical preparations and traditional Chinese medicine for the diagnosis, prevention and treatment of cognitive deficiencies and neurodegenerative diseases and for the treatment of brain and spinal cord diseases or degenerative disorders and for improving neurological abilities
10 Surgical apparatus and instruments for use in the field of gastro-intestinal medicine, orthopedics and ophthalmology; Medical apparatus and instruments, namely, surgical robotic apparatus and non-invasive detection tools in the nature of medical imaging devices for detecting brain plaques; medical and surgical apparatus, instruments and parts therefor for use in magnetic resonance imaging and other imaging-guided surgery, including markers for use in patient registration in the nature of procedures used in computer assisted surgeries and tracking the location of instruments within the patient's body during image guided surgeries; medical and surgical apparatus, instruments and parts therefor for use in minimum invasive surgery; medical apparatus for the treatment of neurodegenerative diseases; medical instruments and articles, namely, analytical apparatus for diagnosis of neurodegenerative diseases; analysis apparatus for medical purposes, namely, non-invasive detection apparatus probes and imaging devices for use in the fields of neurology and neurobiology; diagnostic apparatus for medical purposes, for diagnosing plagues and images in brain for use in the fields of neurology and neurobiology; medical diagnostic apparatus for the detection of neurodegenerative diseases and conditions; surgical, medical apparatus and instruments for the prevention, treatment and repair of neurodegenerative diseases and disorders; medical testing apparatus used for the treatment of cognitive deficiencies, neurodegenerative diseases and for the treatment of brain and spinal cord diseases or degenerative disorders and for improving neurological abilities
42 Pre-clinical and clinical services for pharmaceutical and diagnostic test formulation research, namely, pharmacological studies, toxicokinetic and pharmacokinetic studies, toxicity tests, bioequivalence studies, stability tests, clinical trials, clinical research, medical research in the fields of gastro-intestinal medicine, women's health, orthopedics and ophthalmology; conducting clinical trials for diagnostic tests and for pharmaceutical preparations in the fields of gastro-intestinal medicine, women's health, orthopedics and ophthalmology; scientific and toxicology research services in the fields of gastro-intestinal medicine, women's health, orthopedics and ophthalmology; biopharmaceutical research for development of targeted therapies for use in the treatment of gastrointestinal diseases and disorders, diseases and disorders relating to woman's health, orthopedics and orthopedic injuries and conditions, and ophthalmological diseases, conditions and disorders; providing medical testing services for research purposes and medical and scientific research information in the fields of gastro-intestinal medicine, women's health, orthopedics and ophthalmology; pre- clinical and clinical services for formulation research, namely, pharmacological studies, toxicokinetic and pharmacokinetic studies, toxicity tests, bioequivalence studies, stability tests, clinical trials, clinical research, medical research in the field of neurodegenerative diseases; conducting clinical trials for diagnostic tests and for pharmaceutical preparations in the field of neurodegenerative diseases; scientific and toxicology research services in the field of neuroscience and neurodegenerative diseases; biopharmaceutical research for development of targeted therapies for use in the treatment of neurodegenerative diseases and disorders; providing medical testing services for research purposes and medical and scientific research information in the fields of degenerative and neurodegenerative diseases; consulting for pharmacology and medical toxicology in the fields of gastro-intestinal medicine, women's health, orthopedics and ophthalmology; consulting for pharmacology and toxicology in the field of neurodegenerative diseases and disorders
44 Providing targeted, individualized treatment regimens, therapies or combination therapy for patients suffering from gastro-intestinal diseases and disorders, diseases and disorders relating to woman's health, orthopedics and orthopedic injuries and conditions, and ophthalmological diseases, conditions and disorders; medical testing for diagnostic or treatment purposes in the fields of gastro-intestinal medicine, women's health, orthopedics and ophthalmology; providing targeted, individualized treatment regimens, therapies or combination therapy for patients suffering from neurodegenerative diseases and disorders; medical testing for diagnostic or treatment purposes in the field of neurodegenerative diseases and disorders
Mar 30, 2021
Registered-Principal Register
Jan 12, 2021
Official Gazette Publication Confirmation E-Mailed
Jan 12, 2021
Published For Opposition
Dec 23, 2020
Notification Of Notice Of Publication E-Mailed
Dec 9, 2020
Law Office Publication Review Completed
Nov 30, 2020
Approved For Pub - Principal Register
Nov 30, 2020
Case Returned To Examination
Nov 30, 2020
Notice Of Allowance Cancelled
Nov 30, 2020
Extension 1 Granted
Jun 10, 2020
Extension 1 Filed
Oct 6, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 6, 2020
Teas Change Of Correspondence Received
Oct 6, 2020
Teas Withdrawal As Domestic Representative Received
Oct 6, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 6, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 6, 2020
Teas Change Of Owner Address Received
Jun 10, 2020
Teas Extension Received
Jun 9, 2020
Teas Response To Office Action Received
May 7, 2020
Notification Of Non-Final Action E-Mailed
May 7, 2020
Non-Final Action E-Mailed
May 7, 2020
Non-Final Action Written
Apr 28, 2020
Previous Allowance Count Withdrawn
Apr 10, 2020
Attorney Review/Decision On Amendment Required
Apr 10, 2020
Petition To Director - Change Basis - Granted
Apr 10, 2020
Assigned To Petition Staff
Feb 6, 2020
44(E) Petition - Received
Mar 10, 2020
Case Assigned To Intent To Use Paralegal
Feb 6, 2020
Teas Post Publication Amendment Received
Dec 10, 2019
Noa E-Mailed - Sou Required From Applicant
Oct 15, 2019
Official Gazette Publication Confirmation E-Mailed
Oct 15, 2019
Published For Opposition
Sep 25, 2019
Notification Of Notice Of Publication E-Mailed
Sep 6, 2019
Approved For Pub - Principal Register
Sep 6, 2019
Examiner's Amendment Entered
Sep 6, 2019
Notification Of Examiners Amendment E-Mailed
Sep 6, 2019
Examiners Amendment E-Mailed
Sep 6, 2019
Examiners Amendment -Written
Aug 26, 2019
Notification Of Priority Action E-Mailed
Aug 26, 2019
Priority Action E-Mailed
Aug 26, 2019
Priority Action Written
Aug 2, 2019
Notice Of Revival - E-Mailed
Aug 2, 2019
Teas/Email Correspondence Entered
Aug 2, 2019
Correspondence Received In Law Office
Aug 2, 2019
Assigned To Lie
Aug 2, 2019
Petition Granted - Response Received
Jul 30, 2019
Assigned To Petition Staff
Jun 8, 2019
Teas Response To Office Action Received
Jun 8, 2019
Teas Petition To Revive Received
Dec 7, 2018
Notification Of Non-Final Action E-Mailed
Dec 7, 2018
Non-Final Action E-Mailed
Dec 7, 2018
Non-Final Action Written
Nov 13, 2018
Teas/Email Correspondence Entered
Nov 12, 2018
Correspondence Received In Law Office
Nov 12, 2018
Teas Request For Reconsideration Received
Sep 5, 2018
Notification Of Final Refusal Emailed
Sep 5, 2018
Final Refusal E-Mailed
Sep 5, 2018
Final Refusal Written
Aug 15, 2018
Teas/Email Correspondence Entered
Aug 14, 2018
Correspondence Received In Law Office
Aug 14, 2018
Teas Response To Office Action Received
Feb 14, 2018
Notification Of Non-Final Action E-Mailed
Feb 14, 2018
Non-Final Action E-Mailed
Feb 14, 2018
Non-Final Action Written
Feb 12, 2018
Assigned To Examiner
Nov 11, 2017
New Application Office Supplied Data Entered In Tram
Nov 4, 2017
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
